Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2022-01-27 | 2022-02-25 | 153742 |
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2022-03-10 | 2022-05-19 | 156410 |
TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2022-03-31 | 2022-08-19 | 157642 |
TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2022-04-21 | 2022-06-17 | 159192 |
TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2022-06-03 | 2022-12-08 | 161928 |
TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2022-06-09 | 2023-01-18 | 162271 |
TEVA-TOPISONE | 0.05% | CREAM | Resolved | 2022-06-09 | 2022-08-20 | 162277 |
TEVA-CLOBETASOL | 0.05% | LOTION | Actual shortage | 2022-08-18 | 2022-08-19 | 167162 |
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2022-12-01 | 2022-12-15 | 176788 |
TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2022-12-01 | 2022-12-15 | 176800 |
TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2023-01-19 | 2023-01-26 | 181611 |
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2023-02-16 | 2023-08-04 | 184931 |
TEVA-ECTOSONE | 0.05% | CREAM | Resolved | 2023-06-08 | 2023-11-16 | 194068 |
TEVA-ECTOSONE | 0.05% | LOTION | Resolved | 2023-06-08 | 2024-03-07 | 194074 |
TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2023-06-08 | 2023-10-04 | 194080 |
TEVA-TOPILENE | 0.05% | LOTION | Resolved | 2023-06-08 | 2023-07-15 | 194088 |
TEVA-ECTOSONE | 0.05% | LOTION | Resolved | 2023-06-16 | 2023-07-05 | 195189 |
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2023-06-19 | 2023-07-05 | 195563 |
TEVA-TOPILENE | 0.05% | LOTION | Resolved | 2023-06-19 | 2023-07-05 | 195579 |
TEVA-ECTOSONE | 0.05% | CREAM | Resolved | 2023-06-19 | 2023-07-05 | 195600 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Discontinued | 2020-01-21 | 2020-01-21 | 103788 |
TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |